# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.83) by 6...
HC Wainwright & Co. analyst Matthew Caufield initiates coverage on HilleVax (NASDAQ:HLVX) with a Buy rating and announce...
Guggenheim analyst Seamus Fernandez maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $38 to $34.
Stifel analyst Stephen Willey maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $35 to $30.
HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.84) by 3...
HilleVax Inc (NASDAQ: HLVX) shares are trading lower by 8.5% to $13.20 Wednesday morning after the company announced pricing of...